Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
Adult
Aged
Aged, 80 and over
COVID-19
/ diagnosis
COVID-19 Testing
/ methods
Disease Notification
/ statistics & numerical data
Epidemiological Monitoring
Female
Humans
Male
Middle Aged
Pandemics
Physical Distancing
Prevalence
Real-Time Polymerase Chain Reaction
Respiratory Tract Infections
/ diagnosis
Retrospective Studies
SARS-CoV-2
/ genetics
Seasons
Texas
/ epidemiology
COVID-19
SARS-COV-2
diagnosis
epidemiology
rRT-PCR
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
06
04
2020
revised:
06
05
2020
accepted:
07
05
2020
pubmed:
16
5
2020
medline:
30
12
2020
entrez:
16
5
2020
Statut:
ppublish
Résumé
Rapid diagnosis and isolation are key to containing the quick spread of a pandemic agent like severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), which has spread globally since its initial outbreak in Wuhan province in China. SARS-CoV-2 is novel and the effect on typically prevalent seasonal viruses is just becoming apparent. We present our initial data on the prevalence of respiratory viruses in the month of March 2020. This is a retrospective cohort study post launching of SARS-CoV-2 testing at Baylor Scott and White Hospital (BSWH), Temple, Texas. Testing for SARS-CoV-2 was performed by real-time reverse transcription polymerase chain reaction assay and results were shared with State public health officials for immediate interventions. More than 3500 tests were performed during the first 2 weeks of testing for SARS-CoV-2 and identified 168 (4.7%) positive patients. Sixty-two (3.2%) of the 1912 ambulatory patients and 106 (6.3%) of the 1659 emergency department/inpatients tested were positive. The highest rate of infection (6.9%) was seen in patients aged 25 to 34 years, while the lowest rate of infection was seen among patients aged <25 years old (2%). County-specific patient demographic information was shared with respective public health departments for epidemiological interventions. Incidentally, this study showed that there was a significant decrease in the occurrence of seasonal respiratory virus infections, perhaps due to increased epidemiological awareness about SARS-CoV-2 among the general public, as well as the social distancing measures implemented in response to SARS-CoV-2. Data extracted for BSWH from the Centers for Disease Control and Prevention's National Respiratory and Enteric Virus Surveillance System site revealed that Influenza incidence was 8.7% in March 2020, compared with 25% in March 2019. This study was intended to provide an initial experience of dealing with a pandemic and the role of laboratories in crisis management. This study provided SARS-CoV-2 testing data from ambulatory and inpatient population. Epidemiological interventions depend on timely availability of accurate diagnostic tests and throughput capacity of such systems during large outbreaks like SARS-CoV-2.
Identifiants
pubmed: 32410236
doi: 10.1002/jmv.26010
pmc: PMC7273053
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2130-2138Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
JAMA. 2020 Apr 14;323(14):1343-1344
pubmed: 32125355
JAMA. 2020 Feb 25;323(8):709-710
pubmed: 31999307
J Med Virol. 2020 Oct;92(10):2130-2138
pubmed: 32410236
J Clin Microbiol. 2016 Jul;54(7):1912-1914
pubmed: 27122378
Travel Med Infect Dis. 2020 Jul - Aug;36:101638
pubmed: 32205272
Antiviral Res. 2018 Oct;158:127-134
pubmed: 30059721
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Int J Occup Environ Med. 2020 Feb 5;11(2):65-71
pubmed: 32020915
Travel Med Infect Dis. 2020 Jul - Aug;36:101632
pubmed: 32205269
Clin Infect Dis. 2020 Jul 28;71(15):769-777
pubmed: 32176772
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAMA. 2020 May 26;323(20):2085-2086
pubmed: 32293646
Lancet Infect Dis. 2009 Aug;9(8):473-81
pubmed: 19628172